Gene · 6414
Papers2,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Variability of DNA Repair and Oxidative Stress Genes Associated with Worst Pain in Breast Cancer Survivors on Aromatase Inhibitors. | Genes (Basel) | 2023 | 38002974 | PubTator, text mining | PubMed |
| Serum Selenium-Binding Protein 1 (SELENBP1) in Burn Injury: A Potential Biomarker of Disease Severity and Clinical Course. | Antioxidants (Basel) | 2023 | 38001780 | PubTator, text mining | PubMed |
| Human Monocytes Exposed to SARS-CoV-2 Display Features of Innate Immune Memory Producing High Levels of CXCL10 upon Restimulation. | J Innate Immun | 2023 | 37989107 | PubTator, text mining | PubMed |
| Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer. | Sci Data | 2023 | 37985782 | PubTator, text mining | PubMed |
| "Alphabet" Selenoproteins: Their Characteristics and Physiological Roles. | Int J Mol Sci | 2023 | 37958974 | PubTator, text mining | PubMed |
| MaLiAmPi enables generalizable and taxonomy-independent microbiome features from technically diverse 16S-based microbiome studies. | Cell Rep Methods | 2023 | 37939711 | PubTator, text mining | PubMed |
| Reversal of nonalcoholic fatty liver disease reduces the risk of cardiovascular disease among Korean. | Medicine (Baltimore) | 2023 | 37933021 | PubTator, text mining | PubMed |
| Utilization of sodium-glucose cotransporter 2 inhibitors on dry eye disease severity in patients with type 2 diabetes mellitus. | Int J Med Sci | 2023 | 37928879 | PubTator, text mining | PubMed |
| Physicochemical and microbiological parameters during the manufacturing of a beer-type fermented beverage using selenized Saccharomycesboulardii. | Heliyon | 2023 | 37928392 | PubTator, text mining | PubMed |
| Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study. | Free Radic Biol Med | 2023 | 37923090 | PubTator, text mining | PubMed |
| Single-cell characterization of macrophages in uveal melanoma uncovers transcriptionally heterogeneous subsets conferring poor prognosis and aggressive behavior. | Exp Mol Med | 2023 | 37907747 | PubTator, text mining | PubMed |
| "Alphabet" Selenoproteins: Implications in Pathology. | Int J Mol Sci | 2023 | 37895024 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Role of Gene Variants in Matrix Metalloproteinases and Their Tissue Inhibitors in Retinopathy of Prematurity: A Study in the Polish Population. | Int J Mol Sci | 2023 | 37894989 | PubTator, text mining | PubMed |
| Relationship between Composite Dietary Antioxidant Index and Aging. | Healthcare (Basel) | 2023 | 37893796 | PubTator, text mining | PubMed |
| Oxidative Stress and Male Infertility: The Protective Role of Antioxidants. | Medicina (Kaunas) | 2023 | 37893487 | PubTator, text mining | PubMed |
| Do Dietary Supplements Affect Inflammation, Oxidative Stress, and Antioxidant Status in Adults with Hypothyroidism or Hashimoto's Disease?-A Systematic Review of Controlled Trials. | Antioxidants (Basel) | 2023 | 37891878 | PubTator, text mining | PubMed |
| Selective Impact of Selenium Compounds on Two Cytokine Storm Players. | J Pers Med | 2023 | 37888066 | PubTator, text mining | PubMed |
| Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma. | EBioMedicine | 2023 | 37879219 | PubTator, text mining | PubMed |
| Macrophage polarization and metabolism in atherosclerosis. | Cell Death Dis | 2023 | 37863894 | PubTator, text mining | PubMed |
| Sulforaphane decreases serum selenoprotein P levels through enhancement of lysosomal degradation independent of Nrf2. | Commun Biol | 2023 | 37857700 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6414/papers?page=13